Journal Home
Search for

Volume 34, Issue 2, Pages 200-206 (April 2010)


View previous. 17 of 20 View next.

Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by Polymerase Chain Reaction arrays in human prostate cancer cell lines

Nadège Rabiauabc, Myriam Kossaïab, Martin Braudab, Nasséra Chalabiab, Samir Satihab, Yves-Jean BignonabdCorresponding Author Informationemail address, Dominique J. Bernard-Gallonab

Accepted 30 December 2009. published online 18 January 2010.

Abstract 

Background: The prostate cancer most frequently affects men. The ethnic origin and family antecedents of prostate cancer are established as risk factors. The genetic factors associated with environmental factors such as the nutrition also play a role in the development of the cancer. Epidemiological studies showed that the Asian populations exhibited an incidence of prostate cancer markedly subordinate by comparison with the Western populations. This would be explained partially by their important consumption of soy. Both main phytoestrogens of soy, the genistein and the daidzein, present anti-proliferative properties. Methods: For that purpose, we used different prostate cancer cell lines (LNCaP, DU 145, PC-3) and, by flow cytometry, we determined the concentration of phytoestrogens inducing a cell cycle arrest and the required time of incubation. Results: Then, the effects of 40μM genistein or 110μM daidzein for 48h were determined and studied on the expression of genes involved in the human cell cycle and angiogenesis and conducted by SYBR green quantitative PCR. Conclusion: We demonstrated modulations of cyclin-dependent kinase-related pathway genes, DNA damage-signaling pathway and a down-regulation of EGF and IGF.

a Centre Jean Perrin, Department of Oncogenetics, EA 4233, Centre Biomédical de Recherche et de Valorisation, 28 place Henri Dunant, B.P. 38, 63011 Clermont-Ferrand, France

b CNRH, 58 rue Montalembert, 63009 Clermont-Ferrand, France

c Soluscience, Biopôle Clermont-Limagne, 63360 Saint-Beauzire, France

d Université Clermont I, Faculté de Médecine, 28 place Henri Dunant, 63001 Clermont-Ferrand Cedex 01, France

Corresponding Author InformationCorresponding author at: Centre Jean Perrin, Department of Oncogenetics, EA 4233, Centre Biomédical de Recherche et de Valorisation, 28 place Henri Dunant, B.P. 38, 63011 Clermont-Ferrand, France. Tel.: +33 04 73 27 81 48; fax: +33 04 73 27 80 42.

PII: S1877-7821(10)00003-2

doi:10.1016/j.canep.2009.12.018


View previous. 17 of 20 View next.